Adult GlioblastomaPhase 1NCT04573140Papers
Autologous total tumor mRNA
RNA-lipid Particle (RNA-LP) Vaccines for Newly Diagnosed Pediatric High-Grade Gliomas (pHGG) and Adult Glioblastoma (GBM)
39 Phase 1 studies recruiting right now, most recently updated first.
Open the Phase 2 page · a list of only those studies
Triangle is made by Triangle Health, Inc.
Brain and CNS39 studies
Adult GlioblastomaPhase 1NCT04573140Papers
RNA-lipid Particle (RNA-LP) Vaccines for Newly Diagnosed Pediatric High-Grade Gliomas (pHGG) and Adult Glioblastoma (GBM)
Glioblastoma (GBM)Phase 1/2NCT07346144Papers
An AAV Mediated Dual-Payload Gene Therapy in Patients With High Grade Glioma
Recurrent GlioblastomaPhase 1NCT06815029
Intracranial Genetically Modified Immune Cells (TGFβR2KO/IL13Rα2 CAR T-Cells) for the Treatment of Recurrent or Progressive Glioblastoma or Grade 3 or 4 IDH-Mutant Astrocytoma
Malignant Brain NeoplasmPhase 1NCT04510051Papers
CAR T Cells After Lymphodepletion for the Treatment of IL13Rα2 Positive Recurrent or Refractory Brain Tumors in Children
Medulloblastoma, ChildhoodPhase 1NCT06193759
Immunotherapy for Malignant Pediatric Brain Tumors Employing Adoptive Cellular Therapy (IMPACT)
Relapsed/Refractory DLL3-Expressing TumorsPhase 1/2NCT06814496
Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors
Glioblastoma Multiforme of BrainPhase 1NCT06815432
GPC-3 CAR T CELLS FOR Recurrent GPC-3 Positive Glioblastoma
Recurrent GlioblastomaPhase 1NCT07145112
Laser Interstitial Thermal Therapy (LITT) and Lomustine (CCNU) for Recurrent Glioblastoma
Recurrent GlioblastomaPhase 1NCT03896568Papers
MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma
EGFR-Altered IDH-Wildtype Glioblastoma or GliosarcomaPhase 1NCT07089641
ERAS-801 for the Treatment of Resectable and Progressive or Recurrent or Elderly Newly Diagnosed IDH Wildtype Grade IV Glioblastoma or Gliosarcoma With an EGFR Amplification or Mutation, ERAS801-SARG Trial
Currently Only Enrolling Glioblastoma Patients at First RecurrencePhase 1NCT05139056
Multiple Intracerebral Doses of Neural Stem Cell-Based Virotherapy (NSC-CRAd-S-pk7) for the Treatment of Recurrent High-Grade Gliomas
Recurrent GliosarcomaPhase 1NCT04991870
Phase I CB-NK-TGF-ßR2-/NR3C1- in rGBM
Neoplasms, BrainPhase 1NCT03911388Papers
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
Central Nervous System NeoplasmsPhase 1NCT07390539
B7-H3.CD28Z.CART in CNS Neoplasms
Recurrent GlioblastomaPhase 1NCT07579208
Locoregional Delivery Of Engineered NK Cells Containing IL13Ra And EGFvIII Chimeric Antigen Receptor (CAR), IL-21 Secretion And Deleted TGF-BetaR2 And NR3C1 In Recurrent Glioblastoma
Low Grade Glioma of BrainPhase 1NCT05609994
ViCToRy: Vorasidenib in Combination With Tumor Specific Peptide Vaccine for Recurrent IDH1 Mutant Lower Grade Gliomas
Newly Diagnosed GlioblastomaPhase 1NCT04903795
BRiTE - Bispecific T Cell Engager for Patients With Glioblastoma
Diffuse Intrinsic Pontine GliomaPhase 1NCT04099797Papers
C7R-GD2.CAR T Cells for Patients With GD2-expressing Brain Tumors (GAIL-B)
Recurrent/Progressive Non-Enhancing IDH-Mutant GliomaPhase 1NCT03922555
ASTX727 in Recurrent/Progressive Non-enhancing IDH Mutant Gliomas
High Grade GliomaPhase 1/2NCT05278208Papers
Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors
GlioblastomaPhase 1NCT05660369Papers
CARv3-TEAM-E T Cells in Glioblastoma
High Grade GliomaPhase 1NCT06428045Papers
STARLITE for Unresectable High-Grade Gliomas
GliomaPhase 1NCT07541781
Sitagliptin in Recurrent/Progressive Grade 4 Glioma
Recurrent Diffuse Hemispheric Glioma, H3 G34-MutantPhase 1NCT06914479
Virus-Based Gene Therapy (AdV-HSV1-TK and AdV-Flt3L) in Combination With Valacyclovir for the Treatment of Pediatric and Young Adult Patients With Resectable, Recurrent Primary Malignant Brain Tumors